CClinicalTrials.gg
CompletedNCT03176082MFITUpdated Dec 20, 2018

Mailed Reminders Plus Fecal Immunochemical Testing

An interventional study of Mailed Reminders with Fecal Immunochemical Testing kits and Reminder letter only in Colorectal Cancer Screening and Colorectal Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center. Completed. Open to participants aged 52 Years to 64 Years. Per ClinicalTrials.gov, last updated 2018-12-20.

Sponsored by UNC Lineberger Comprehensive Cancer Center · Not applicable, Interventional, and Screening

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Oct 2016, registered May 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
2,144
Allocation
Randomized
Ages
52 Years to 64 Years
Sex
All
01

Study summary

Purpose: The investigators propose to test the effectiveness, feasibility, and cost-effectiveness of a mailed reminder with and without FIT kits in a population of Medicaid enrollees in Mecklenburg County.

Read the detailed description

Purpose: The investigators propose to test the effectiveness, feasibility, and cost-effectiveness of a mailed reminder with and without FIT kits in a population of Medicaid enrollees in Mecklenburg County.

Participants: Medicaid beneficiaries who are enrolled in Community Care of North Carolina, ages 52-64, currently living in Mecklenburg County, at average risk for colorectal cancer (CRC), with no record of recent CRC screening (FOBT within 12 months, colonoscopy within 10 years).

Procedures (methods): Participants will be identified through the state Medicaid database and randomized to receive either: 1) a mailed reminder to complete CRC screening including a FIT kit, instructions for completion, and a return mailer, OR 2) a mailed reminder to complete CRC screening only.

Any recipients testing positive will be guided by care managers from Community Care of North Carolina to ensure a follow-up colonoscopy is completed.

02

Conditions studied

  • Colorectal Cancer Screening
  • Colorectal Cancer

Keywords

  • colorectal cancer screening
  • colorectal cancer
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's enrollment of 2,144 is above the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

UNC Lineberger Comprehensive Cancer Center is the lead sponsor of 414 studies on the registry; 96 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 25 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
52 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Current Medicaid beneficiary,
  2. Enrolled in Community Care Partners of Greater Mecklenburg (CCPGM),
  3. 52-64 years old,
  4. English or Spanish speaking,
  5. No record of FOBT/FIT within 12 months or colonoscopy with 10 years, sigmoidoscopy within 5 years; barium enema within 5 years, CT colonography within 10 years,
  6. No record of any CRC diagnosis or total colectomy

Exclusion criteria

Exclusion Criteria:

  1. \< 52 or >64 years of age;
  2. History of colorectal cancer or total colectomy (see attached table for codes),
  3. Persons dually enrolled in Medicare,
  4. Not enrolled in CCPGM, 5. Received FOBT or FIT within 12 months; colonoscopy within 10 years; sigmoidoscopy within 5 years; barium enema within 5 years, CT colonography within 10 years
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,144 participants (actual)

Study arms

  • Experimental
    Intervention Group

    Intervention group will receive: 1. A reminder letter indicating need for screening 2. A FIT kit with completion instructions 3. A health information card including the ability to update records for current screening and opt out from colon cancer screening communication from the Mecklenburg County Public Health Department (MCPHD) 4. A pre-paid return mailer for FIT Kit

    Other: Mailed Reminders with Fecal Immunochemical Testing kits

  • Active comparator
    Comparison Group

    Comparison group will receive: 1. A reminder letter indicating need for screening 2. Instructions for obtaining a FIT kit 3. A health information card including the ability to update records for current screening and opt out from colon cancer screening communication from the MCPHD

    Other: Reminder letter only

Interventions

  • OtherMailed Reminders with Fecal Immunochemical Testing kits
  • OtherReminder letter only
06

What researchers measure

Primary outcomes

  1. Number of participants who completed fecal testing, screening colonoscopy, and colonoscopies following positive fecal testing, •

    Screening status will be assessed through participant response and Medicaid claim data.

    Time frame: 21 months following baseline

  2. Diagnoses of colorectal Cancer

    Diagnoses of colorectal cancer will be assessed through Medicaid claim data.

    Time frame: 21 months following baseline

  3. Polypectomies

    Number of polypectomies will be assessed through Medicaid claim data.

    Time frame: 21 months following baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 20, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03176082
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Responsible party
Sponsor
First posted
Jun 5, 2017
Start date
Oct 2016
Primary completion
Jul 2018
Completion
Jul 2018
Last update
Dec 20, 2018

Study contacts

Alison Brenner, PhD, MPH
principal investigator · UNC Lineberger Comprehensive Cancer Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion